Marina Biotech, Inc. to Present at Biotech Showcase 2012
Company Will Update on Recent Licensing Transaction and Near-Term Value Drivers
(firmenpresse) - BOTHELL, WA -- (Marketwire) -- 01/03/12 -- Marina Biotech, Inc. (NASDAQ: MRNAD), a leading oligonucleotide-based drug discovery and development company, announced today that it will present at Biotech Showcase 2012 on Tuesday, January 10, 2012, at 5:30 p.m. Eastern Time (2:30 p.m. Pacific Time) at the Parc 55 Wyndham San Francisco in San Francisco. J. Michael French, Marina Biotech President and Chief Executive Officer, will present a corporate overview, the recent Mirna Therapeutics licensing agreement and near-term value drivers.
A live audio webcast will be available on the Event Calendar pages of the Investors section of the Company's website at . Please allow time prior to the presentation to register and download any necessary software. A replay of the presentation will be available on the Investors section of the Marina Biotech website under Event Calendar approximately one hour after the live presentation.
About Marina Biotech, Inc.
Marina Biotech is a biotechnology company, focused on the development and commercialization of oligonucleotide-based therapeutics utilizing multiple mechanisms of action including RNA interference (RNAi) and messenger RNA translational blocking. The Marina Biotech pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome) and two preclinical programs -- in bladder cancer and malignant ascites. Marina Biotech entered into an exclusive agreement with The Debiopharm Group for the development and commercialization of the bladder cancer program. Marina Biotech's goal is to improve human health through the development of RNAi- and oligonucleotide-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Additional information about Marina Biotech is available at .
Contact:
Marina Biotech, Inc.
Phil Ranker
Interim Chief Financial Officer
(425) 908-3615
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.01.2012 - 11:30 Uhr
Sprache: Deutsch
News-ID 100485
Anzahl Zeichen: 0
contact information:
Town:
BOTHELL, WA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 166 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Marina Biotech, Inc. to Present at Biotech Showcase 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
Marina Biotech, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
